Most Active Biotech Investors in Redwood City 2026

8 firms writing Biotech checks in Redwood City, led by 5AM Ventures, HBM Healthcare Investments.

Biotech in Redwood City accounts for 5 tracked companies with verified cap-table data, 5 of which disclose round sizes totalling $1.4B. The median disclosed raise is $180M, and the largest is MapLight Therapeutics at $699M, ahead of Gynesonics ($338M) and Retro Biosciences ($180M).

The names that recur most often on these biotech cap tables are Forbion (2 companies), Life Sciences at Goldman Sachs Alternatives (1 company), Sanofi (1 company), T. Rowe Price Investment Management, Inc. (1 company), Avego BioScience Capital (1 company), Novo Holdings (1 company). By latest disclosed round, the market skews Series D (1), Series F (1), Seed (1), Series A (1).

Companies tracked: 5
Disclosed funding total: $1.4B across 5 companies
Median disclosed raise: $180M
Largest raise: MapLight Therapeutics — $699M
Stage mix: Series D 1 · Series F 1 · Seed 1 · Series A 1
Most recent dated round: 2025-07-28

Best funded Biotech in Redwood City companies

MapLight Therapeutics — $699M (latest: Series D)
Gynesonics — $338M (latest: Series F)
Retro Biosciences — $180M (latest: Seed)
Mosanna Therapeutics — $80M (latest: Series A)
Pulmonx — $66M

Sector × city funding reports (20)

All research · Investor directory · Company funding database · Fundraising library